Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

10.1016/j.vaccine.2009.06.098

Saved in:

Bibliographic Details
Main Authors:	Russell, F.M., Balloch, A., Tang, M.L.K., Carapetis, J.R., Licciardi, P., Nelson, J., Jenney, A.W.J., Tikoduadua, L., Waqatakirewa, L., Pryor, J., Byrnes, G.B., Cheung, Y.B., Mulholland, E.K.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Subjects:	Pneumococcal conjugate vaccine
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110562
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
by: Russell, F.M., et al.
Published: (2014)

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
by: Russell, F.M., et al.
Published: (2014)

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
by: Russell, F.M., et al.
Published: (2014)

Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020)

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
by: Russell, F.M., et al.
Published: (2014)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?
by: Wantanee Kulpenga, et al.
Published: (2014)

Climate induces seasonality in pneumococcal transmission.
by: Numminen, Elina, et al.
Published: (2015)

pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion
by: Iovino, Federico, et al.
Published: (2017)

Continued control of pneumococcal disease in the UK - The impact of vaccination
by: Gladstone, R.A, et al.
Published: (2020)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Feikin D.R., et al.
Published: (2019)

Clonal Expansion within Pneumococcal Serotype 6C after Use of Seven-Valent Vaccine
by: Loman N.J., et al.
Published: (2019)

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
by: Lim, F.S, et al.
Published: (2020)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: A questionnaire-based assessment
by: How, C.H, et al.
Published: (2020)

Nasopharyngeal carriage of streptococcus pneumoniae in gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings
by: Cheung, Y.-B., et al.
Published: (2014)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Mohapi L.
Published: (2023)

Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
by: Haasis M.A., et al.
Published: (2020)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
by: Wilck M.
Published: (2023)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Lerato Mohapi, et al.
Published: (2022)

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media
by: Bogaert, D, et al.
Published: (2020)

Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia
by: Paul Turner, et al.
Published: (2018)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
by: Ngamprasertchai T.
Published: (2023)

Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore
by: Hsu, L.-Y., et al.
Published: (2015)

Pneumococcal Pneumonia Resembling Acute Myocardial Infarction in an Adolescent Male
by: Chiong, Yee Keow, et al.
Published: (2021)

Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, C.F., et al.
Published: (2021)

Nasopharyngeal bacterial carriage in the conjugate vaccine era with a focus on pneumococci
by: Devine, V.T, et al.
Published: (2020)

Pneumococcal colonization and severity of pneumonia in hospitalized Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine
by: Miliya T.
Published: (2023)

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
by: Mooney, J.D, et al.
Published: (2020)

Pneumococcal serosurveillance: one piece of the puzzle
by: Licciardi P.V.
Published: (2023)

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children
by: Paul Turner, et al.
Published: (2020)

Immunogenicity and safety of a 9-valent HPV vaccine
by: Pierre Van Damme, et al.
Published: (2018)

Increase in serotype 6C pneumococcal carriage, United Kingdom
by: Tocheva, A.S, et al.
Published: (2020)

Predictors for bacteremia in febrile sickle cell disease children in the post-7-valent pneumococcal conjugate vaccine era
by: Todd P. Chang, et al.
Published: (2018)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
by: Wantanee Kulpeng, et al.
Published: (2018)

Synthesis and characterization of novel fluorene-thiophene-based conjugated copolymers
by: Liu, B., et al.
Published: (2014)

Synthesis and characterization of a novel conjugated polymer containing PPV oligomer and fluorene
by: Lu, S., et al.
Published: (2014)

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children
by: Chareeya Thanee, et al.
Published: (2018)

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)
by: Bili A.
Published: (2023)

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants from Asian Countries
by: S. M. Garland, et al.
Published: (2019)

A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
by: Lupinacci R.
Published: (2023)

An efficient fluorescent chemosensor for Mg2+: Selective and high sensitive
by: Ding, A.-L., et al.
Published: (2014)